BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19362418)

  • 1. Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use?
    Vo T; Rice ASC; Dworkin RH
    Pain; 2009 Jun; 143(3):169-171. PubMed ID: 19362418
    [No Abstract]   [Full Text] [Related]  

  • 2. What can we learn from failed neuropathic pain trials?
    Polydefkis M; Raja SN
    Neurology; 2008 Jan; 70(4):250-1. PubMed ID: 18209199
    [No Abstract]   [Full Text] [Related]  

  • 3. Toward a definition of pharmacoresistant neuropathic pain.
    Hansson PT; Attal N; Baron R; Cruccu G
    Eur J Pain; 2009 May; 13(5):439-40. PubMed ID: 19324579
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug treatment of pain originating from the peripheral nervous system].
    Vecht CJ; Alting van Geusau RB
    Ned Tijdschr Geneeskd; 1990 Jan; 134(2):63-8. PubMed ID: 1967488
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral control of inflammatory but not neuropathic pain by endogenous cholinergic system.
    Motta PG; Perez AC; Alves DP; Duarte ID
    Pharmacology; 2011; 88(1-2):18-25. PubMed ID: 21720188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathic pain in leprosy.
    Haanpää M; Lockwood DN; Hietaharju A
    Lepr Rev; 2004 Mar; 75(1):7-18. PubMed ID: 15072122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic management part 1: better-studied neuropathic pain diseases.
    Backonja MM; Serra J
    Pain Med; 2004 Mar; 5 Suppl 1():S28-47. PubMed ID: 14996228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphenyl diselenide attenuates acute thermal hyperalgesia and persistent inflammatory and neuropathic pain behavior in mice.
    Savegnago L; Jesse CR; Pinto LG; Rocha JB; Nogueira CW
    Brain Res; 2007 Oct; 1175():54-9. PubMed ID: 17888416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling neuropathic pain in HIV.
    Verma S; Estanislao L; Mintz L; Simpson D
    Curr HIV/AIDS Rep; 2004 Sep; 1(3):136-41. PubMed ID: 16091234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Definition and classification of neuropathic pain].
    Bouhassira D
    Presse Med; 2008 Feb; 37(2 Pt 2):311-4. PubMed ID: 18191365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the biologic and clinical effects of the COX-2-specific inhibitors an advance compared with the effects of traditional NSAIDs?
    Simon LS
    Curr Opin Rheumatol; 2000 May; 12(3):163-70. PubMed ID: 10803743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of neuropathic pain and their implications for the design of clinical trials.
    Rowbotham MC
    Neurology; 2005 Dec; 65(12 Suppl 4):S66-73. PubMed ID: 16385106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The yin yang of inflammation: inducible and constitutive cyclooxygenase. Nimesulide and selective inhibitors of inducible cyclooxygenase].
    Cirino G; Coppini A; Bigini C; Mitchell JA
    Eur Rev Med Pharmacol Sci; 1998; 2(3 Suppl 1):1-8. PubMed ID: 10887524
    [No Abstract]   [Full Text] [Related]  

  • 14. Central pituitary adenylate cyclase 1 receptors modulate nociceptive behaviors in both inflammatory and neuropathic pain states.
    Davis-Taber R; Baker S; Lehto SG; Zhong C; Surowy CS; Faltynek CR; Scott VE; Honore P
    J Pain; 2008 May; 9(5):449-56. PubMed ID: 18337184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase Inhibition: Pain, Inflammation, and the Cardiovascular System.
    Grosser T; Theken KN; FitzGerald GA
    Clin Pharmacol Ther; 2017 Oct; 102(4):611-622. PubMed ID: 28710775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of etodolac, a COX-2 inhibitor, on neuropathic pain in a rat model.
    Suyama H; Kawamoto M; Gaus S; Yuge O
    Brain Res; 2004 Jun; 1010(1-2):144-50. PubMed ID: 15126127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammation, nonsteroidal anti-inflammatory drugs and Alzheimer disease].
    Lacomblez L
    Psychol Neuropsychiatr Vieil; 2004 Dec; 2(4):298-9. PubMed ID: 15706674
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings.
    Gore M; Dukes E; Rowbotham DJ; Tai KS; Leslie D
    Eur J Pain; 2007 Aug; 11(6):652-64. PubMed ID: 17126045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain.
    Bordet T; Pruss RM
    Neurotherapeutics; 2009 Oct; 6(4):648-62. PubMed ID: 19789070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase enzymes in allergic inflammation and asthma.
    Carey MA; Germolec DR; Langenbach R; Zeldin DC
    Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):157-62. PubMed ID: 12895598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.